Data / Form D filings / Pediapharm Inc.
Pediapharm Inc.: Form D filings
Pediapharm Inc., a pharmaceuticals company in Verdun, Quebec, Canada, filed 2 Form D notices with the SEC in 2018. The latest, on October 30, 2018, reports $95,892 sold of a $95,892 offering to 2 investors.
Find out what Pediapharm Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 225 - 1 PLACE DU COMMERCE, Verdun, Quebec, Canada, H3E 1
- Phone
- (514) 762-2626
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Year incorporated
- 2013
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757261
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2018 | New notice | $95,892 | $95,892 | $0 | 2 | Oct 16, 2018 | sec.gov |
| Oct 26, 2018 | New notice | $21,846,194 | $7,669,889 | $14,176,305 | 1 | Oct 11, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sylvain Chretien | Executive Officer, Director | |
| Pierre Lapalme | Director | |
| Normand Chartrand | Director | |
| Roland Boivin | Executive Officer | |
| Benoit Gravel | Director | |
| Michael Mueller | Director |
Every Form D from the week of Oct 29, 2018 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pediapharm Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.